VS
Harvest Healthcare Leaders Income ETF (HHL) and Hamilton Healthcare Yield Maximizer ETF (LMAX) offer distinct profiles for Canadian ETF investors. A direct comparison shows that HHL focuses its top 3 sector exposures on Healthcare and Sovereign, while LMAX leans towards Healthcare and Consumer Non-Cyclicals. When evaluating costs, HHL features a management fee (MER) of 0.85%, compared to 0.65% for LMAX. Performance-wise, HHL has returned 0.32% year-to-date with +$354 M in net flows, whereas LMAX is at 4.77% with +$71 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
HHL
LMAX
| AuM | $1,833.20 M | $226.66 M |
| Management Fees | 0.85% | 0.65% |
| Exp. ratio | 0.98% | 0.80% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 9, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | HHL | -3.52% | +4.74% | -0.32% | +8.86% | +18.71% |
LMAX | -2.38% | +5.40% | +4.77% | +13.67% | - | |
| Flows | HHL | -$1 M | +$41 M | +$354 M | +$356 M | +$688 M |
LMAX | +$5 M | +$16 M | +$71 M | +$85 M | - |
HHL vs LMAX exposure
Countries
HHL
USA
84.21%
Other
15.79%
LMAX
USA
95.96%
Sectors
HHL
Healthcare
98.89%
LMAX
Healthcare
94.79%
As of September 9, 2026
Top 10 Holdings
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
LMAX
AbbVie, Inc.
5.92%
CVS Health Corp.
5.89%
UnitedHealth Group, Inc.
5.86%
Eli Lilly & Co.
5.77%
Thermo Fisher Scientific, Inc.
5.75%
Bristol Myers Squibb Co.
5.50%
Amgen, Inc.
5.25%
Johnson & Johnson
5.21%
Merck & Co., Inc.
5.20%
Abbott Laboratories
5.09%
Diversification
HHL
Total weight of top 10 holdings out of 25 total
50.34%
LMAX
Total weight of top 10 holdings out of 20 total
55.45%
Characteristics
Compare
HHL
LMAX
| Provider | Harvest Portfolios Group | Hamilton ETFs |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 10.03% | 12.50% |
| Meets ESG criteria | No | No |
| Inception Date | December 18, 2014 | February 6, 2024 |
Frequently asked questions about HHL and LMAX
Which ETF has performed better year to date: HHL or LMAX?
As of September 9, 2026, HHL has returned -0.32% year to date, while LMAX has returned 4.77%. LMAX is ahead on YTD performance.
Which ETF is larger by assets under management: HHL or LMAX?
As of September 9, 2026, HHL manages $1.83 B in assets, while LMAX manages $226.66 M. HHL is the larger fund by AUM.
How are HHL and LMAX managed?
HHL is actively managed by Harvest Portfolios Group. It does not track an index. LMAX is actively managed by Hamilton ETFs. It does not track an index.
What sectors do HHL and LMAX emphasize?
HHL is most exposed to Healthcare and Sovereign. LMAX is most exposed to Healthcare and Consumer Non-Cyclicals.
Which ETF is attracting more investor flows: HHL or LMAX?
Year to date, HHL has seen +$354.17 M in net flows, compared with +$71.11 M for LMAX. HHL has attracted more net investor money so far.
How do the fees of HHL and LMAX compare?
HHL has an expense ratio of 0.98%, while LMAX has an expense ratio of 0.80%.
What are the top holdings of HHL and LMAX?
HHL's largest holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co.. LMAX's top holdings include AbbVie, Inc., CVS Health Corp., and UnitedHealth Group, Inc..
Which ETF is more diversified: HHL or LMAX?
HHL holds 25 securities, while LMAX holds 20. On holdings count, HHL is the more diversified portfolio.
Recent articles about HHL and LMAX
Yield-focused ETFs and the Benefit They Can Provide Investors
ETFs that employ covered call-writing strategies can be effective ways to generate monthly yield for investors while still providing exposure to a security or asset class on a long-term basis.
Posted on 6/13/2024 by Kyle Anthony inStock Market
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.